Literature DB >> 2058558

Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.

I C Van Gelder1, H J Crijns, W H Van Gilst, R Verwer, K I Lie.   

Abstract

The present study was undertaken to reassess prospectively the immediate and long-term results of direct-current electrical cardioversion in chronic atrial fibrillation or atrial flutter, and to determine factors predicting clinical outcome of the arrhythmia after direct-current cardioversion. Two-hundred forty-six patients underwent direct-current electrical cardioversion and were followed during a mean of 260 days. Multivariate analysis was used to identify factors predicting short- and long-term arrhythmia outcome. Cardioversion was achieved in 70% of patients with atrial fibrillation and in 96% of patients with atrial flutter. Stepwise logistic regression analysis revealed that arrhythmia duration (p less than 0.001), type of arrhythmia (fibrillation vs flutter, p less than 0.02) and age (p less than 0.05) independently influenced conversion rate. On an actuarial basis, 42 and 36% of patients remained in sinus rhythm during 1 and 2 years, respectively. Multivariate regression analysis revealed that the type of arrhythmia (p = 0.0008), low precardioversion functional class (p = 0.002) and the presence of nonrheumatic mitral valve disease (p = 0.03) independently increased the length of the arrhythmia-free episode. Rheumatic heart disease shortened this period (p = 0.03). In conclusion, patients having a high probability of conversion together with a prolonged post-shock arrhythmia-free episode can be identified. This may improve the cost-benefit ratio of cardioversion.

Entities:  

Mesh:

Year:  1991        PMID: 2058558     DOI: 10.1016/0002-9149(91)90707-r

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  65 in total

1.  Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study.

Authors:  E Bertaglia; D D'Este; A Zanocco; F Zerbo; P Pascotto
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

2.  Acute pressure overload cardiac arrhythmias are dependent on the presence of myocardial tissue catecholamines.

Authors:  A J Drake-Holland; M I Noble; M J Lab
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

3.  Determinants of successful direct current cardioversion for atrial fibrillation and flutter: the importance of rapid referral.

Authors:  A R Houghton; A Sharman; J E Pohl
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

4.  Anticoagulation for patients with atrial fibrillation. Editorial may have overinterpreted data.

Authors:  N Dudley
Journal:  BMJ       Date:  2000-09-09

Review 5.  Recent developments in atrial fibrillation.

Authors:  M Bilal Iqbal; Anil K Taneja; Gregory Y H Lip; Marcus Flather
Journal:  BMJ       Date:  2005-01-29

6.  The outcome of direct current cardioversion (DCC) for the treatment of atrial fibrillation (AF) in a district general hospital in Ireland.

Authors:  K P O'Rourke; C Cotter; D Mullane; P Thorpe; P Sullivan
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

7.  Prospective randomized trial of external versus internal transcatheter cardioversion in patients with chronic atrial fibrillation.

Authors:  K E Paravolidakis; T M Kolettis; G N Theodorakis; I A Paraskevaidis; T S Apostolou; D T Kremastinos
Journal:  J Interv Card Electrophysiol       Date:  1998-09       Impact factor: 1.900

Review 8.  50-Year-Old Man With Dyspnea on Exertion, Orthopnea, and Weight Gain.

Authors:  Sae K Jang; Megha Prasad; LaPrincess C Brewer
Journal:  Mayo Clin Proc       Date:  2019-08       Impact factor: 7.616

9.  Higher energy monophasic DC cardioversion for persistent atrial fibrillation: is it time to start at 360 joules?

Authors:  C Boos; M D Thomas; A Jones; E Clarke; G Wilbourne; R S More
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

10.  Effects of P-wave dispersion on atrial fibrillation in patients with acute anterior wall myocardial infarction.

Authors:  Merih Baykan; Sükrü Celik; Cevdet Erdöl; Ismet Durmuş; Cihan Orem; Mehmet Küçükosmanoğlu; Remzi Yilmaz
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.